Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Fortis inks pact to...

    Fortis inks pact to acquire portfolio of RHT Health Trust

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-02-14T19:14:36+05:30  |  Updated On 14 Feb 2018 7:14 PM IST
    Fortis inks pact to acquire portfolio of RHT Health Trust

    New Delhi: Fortis Healthcare today said it has entered into definitive agreements with Singh Brothers- promoted RHT Health Trust (RHT) to acquire an entire portfolio of assets of the Singapore-listed entity for an enterprise value of Rs 4,650 crore.


    The definitive agreement to acquire all the securities of clinical establishments and businesses indirectly held by RHT follows the approval of Fortis board in November last year for a major restructuring aimed at consolidating the entire Indian asset portfolio, the company said in a BSE filing.



    Last year, Fortis Healthcare board had approved the proposed acquisition of an entire portfolio of Singapore-listed RHT Health Trust (RHT) for an enterprise value of around Rs 4,650 crore.



    RHT is promoted by brothers -- Malvinder Singh and Shivinder Singh -- who had recently resigned from the board of Fortis Healthcare.

    The step was a part of a restructuring initiative aimed at consolidating the entire Indian asset portfolio comprising various clinical establishments and two operating hospitals of RHT Health Trust into Fortis.

    The assets include 12 clinical establishments, four greenfield establishment and two operating hospitals, Fortis Healthcare said.

    "The proposed acquisition involves the acquisition of all the securities of RHTs entities in India holding (directly or indirectly) clinical establishments and businesses via a purchase of securities for an enterprise value of approximately Rs 4,650 crore," the company said.

    This includes debt of around Rs 1,152 crore, which will be repaid, it added.

    The company further said it is expected that a substantial part of net proceeds from the consideration, after repaying debts and transaction expenses, received by RHT would be distributed to its unit-holders, including Fortis, thereby reducing the net investment consideration that Fortis would incur.

    Fortis said, "it is a controlling unitholder with an indirect interest of 29.76 percent in RHT."

    The company had used proceeds from listing of RHT on Singapore stock in October 2012 exchange to deleverage its balance sheet. It had also entered into hospital and management services agreement with entities held by RHT, for which it paid service fees.

    Claiming that the proposed transaction would potentially enhance value for its stakeholders, Fortis also said with the unwinding of structure, it would also make it easier for investors and other stakeholders to better understand the company's business and financial performance.

    "Upon completion of the securities acquisition, the service fees that Fortis was paying will be completely eliminated thereby improving significantly its operating profitability and cash flows," it said.

    The expected incremental improvement in EBITDA would be approximately Rs 270 crore and in addition, with the acquisition of 49 percent of Fortis Hospital Ltd (FHTL), which is a part of this proposed transaction, there will be an interest saving of around Rs 75 crore on an annualised basis, it said.

    Fortis said it would fund the proposed transaction with a combination of equity, quasi-equity and/or debt.

    The company further said it has an enabling resolution to raise capital of up to Rs 5,000 crore and it has been in active dialogue with financial/strategic investors to raise funds, supported by Standard Chartered Bank as its financial advisor for this purpose.

    The proposed transaction is subject to regulatory and shareholder approvals.

    agreementBSEEBITDAFHTLFortisFortis HealthcareFortis Hospital LtdHealth Trustinks pactMalvinder Singhportfolioproposed acquisitionRHTRHT Health TrustShivinder SinghstakeholdersStandard Chartered Bank
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok